Acutaas Chemicals Ltd.
Acutaas Chemicals Ltd. Fundamental Analysis
Acutaas Chemicals Ltd. (ACUTAAS.NS) shows moderate financial fundamentals with a PE ratio of 67.84, profit margin of 26.60%, and ROE of 24.42%. The company generates $13.4B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ACUTAAS.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentACUTAAS.NS demonstrates superior asset utilization.
Valuation Score
ModerateACUTAAS.NS shows balanced valuation metrics.
Growth Score
ModerateACUTAAS.NS shows steady but slowing expansion.
Financial Health Score
ExcellentACUTAAS.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateACUTAAS.NS maintains healthy but balanced margins.
Key Financial Metrics
Is ACUTAAS.NS Expensive or Cheap?
P/E Ratio
ACUTAAS.NS trades at 67.84 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ACUTAAS.NS's PEG of 0.57 indicates potential undervaluation.
Price to Book
The market values Acutaas Chemicals Ltd. at 14.62 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 48.11 times EBITDA. This signals the market has high growth expectations.
How Well Does ACUTAAS.NS Make Money?
Net Profit Margin
For every $100 in sales, Acutaas Chemicals Ltd. keeps $26.60 as profit after all expenses.
Operating Margin
Core operations generate 33.18 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $24.42 in profit for every $100 of shareholder equity.
ROA
Acutaas Chemicals Ltd. generates $17.96 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Acutaas Chemicals Ltd. produces operating cash flow of $2.09B, showing steady but balanced cash generation.
Free Cash Flow
Acutaas Chemicals Ltd. generates weak or negative free cash flow of $-482.10M, restricting financial flexibility.
FCF Per Share
Each share generates $-5.89 in free cash annually.
FCF Yield
ACUTAAS.NS converts -0.20% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
67.84
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.57
vs 25 benchmark
P/B Ratio
Price to book value ratio
14.62
vs 25 benchmark
P/S Ratio
Price to sales ratio
18.04
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.82
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.24
vs 25 benchmark
ROA
Return on assets percentage
0.18
vs 25 benchmark
ROCE
Return on capital employed
0.25
vs 25 benchmark
How ACUTAAS.NS Stacks Against Its Sector Peers
| Metric | ACUTAAS.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 67.84 | 24.70 | Worse (Expensive) |
| ROE | 24.42% | 1017.00% | Weak |
| Net Margin | 26.60% | -111114.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.51 | Strong (Low Leverage) |
| Current Ratio | 3.82 | 6.11 | Strong Liquidity |
| ROA | 17.96% | -6758.00% (disorted) | Strong |
ACUTAAS.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Acutaas Chemicals Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value